| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside diphosphate kinase activity | 1.70e-04 | 21 | 104 | 3 | GO:0004550 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 2.25e-04 | 23 | 104 | 3 | GO:0030215 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | ZBED2 WNT7B SEMA5A APOE ADGRA2 AXIN1 DACT1 WNT16 CAPRIN2 INVS | 7.32e-06 | 344 | 101 | 10 | GO:0060070 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | ZBED2 WNT7B SEMA5A APOE ADGRA2 AXIN1 TGFB1I1 DACT1 CELSR2 WNT16 CAPRIN2 INVS | 8.36e-06 | 516 | 101 | 12 | GO:0016055 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 CAPRIN2 SEMA4A PLXNB1 | 1.67e-05 | 748 | 101 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 1.83e-05 | 11 | 101 | 3 | GO:0006228 | |
| GeneOntologyBiologicalProcess | cell junction organization | WNT7B FBF1 FRMPD2 ADGRB1 ADGRB2 LAMA3 APOE CSMD2 NEDD9 DACT1 DST TENM3 CAPRIN2 SEMA4A PEAK1 PLXNB1 | 1.98e-05 | 974 | 101 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | GTP biosynthetic process | 3.15e-05 | 13 | 101 | 3 | GO:0006183 | |
| GeneOntologyBiologicalProcess | UTP metabolic process | 3.15e-05 | 13 | 101 | 3 | GO:0046051 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.32e-05 | 124 | 101 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 CAPRIN2 SEMA4A PLXNB1 | 3.59e-05 | 802 | 101 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 CAPRIN2 SEMA4A PLXNB1 | 4.51e-05 | 819 | 101 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron projection development | HAP1 WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 TENM3 CAPRIN2 SEMA4A NME1 NME2 PLXNB1 | 4.73e-05 | 1285 | 101 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 CAPRIN2 SEMA4A PLXNB1 | 4.94e-05 | 826 | 101 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 4.97e-05 | 15 | 101 | 3 | GO:0006241 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 6.09e-05 | 16 | 101 | 3 | GO:0009209 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 7.37e-05 | 17 | 101 | 3 | GO:0046036 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 8.02e-05 | 285 | 101 | 8 | GO:0060828 | |
| GeneOntologyBiologicalProcess | axonogenesis | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DST SEMA4A PLXNB1 | 1.03e-04 | 566 | 101 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate metabolic process | 1.04e-04 | 19 | 101 | 3 | GO:0009208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate biosynthetic process | 1.22e-04 | 20 | 101 | 3 | GO:0009148 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.55e-04 | 494 | 101 | 10 | GO:0031346 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE SIPA1 TENM2 DACT1 DST CELSR2 CAPRIN2 SEMA4A PLXNB1 BRWD1 | 2.19e-04 | 1194 | 101 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 2.42e-04 | 25 | 101 | 3 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 2.42e-04 | 25 | 101 | 3 | GO:0009147 | |
| GeneOntologyBiologicalProcess | neuron development | HAP1 WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DACT1 DST CELSR2 TENM3 CAPRIN2 SEMA4A NME1 NME2 PLXNB1 | 2.44e-04 | 1463 | 101 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon development | WNT7B ADGRB1 LAMA3 LAMB1 SEMA5A LHX3 APOE TENM2 DST SEMA4A PLXNB1 | 3.06e-04 | 642 | 101 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 3.23e-04 | 121 | 101 | 5 | GO:0090263 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FNIP2 HAP1 PIEZO1 AZU1 ADGRB1 ADGRB2 SEMA5A APOE TENM2 NEDD9 TENM3 CAPRIN2 SORBS3 SEMA4A NME1 NME2 PLXNB1 | 3.25e-04 | 1366 | 101 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 3.52e-04 | 6 | 101 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | GTP metabolic process | 3.80e-04 | 29 | 101 | 3 | GO:0046039 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 4.55e-04 | 368 | 101 | 8 | GO:0030111 | |
| GeneOntologyBiologicalProcess | cell junction assembly | FBF1 FRMPD2 ADGRB1 ADGRB2 LAMA3 CSMD2 DST SEMA4A PEAK1 PLXNB1 | 4.78e-04 | 569 | 101 | 10 | GO:0034329 |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 4.91e-04 | 7 | 101 | 2 | GO:0006231 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine maintenance | 4.91e-04 | 7 | 101 | 2 | GO:1902952 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 4.91e-04 | 7 | 101 | 2 | GO:0009177 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.08e-04 | 285 | 101 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.19e-04 | 286 | 101 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | synapse organization | WNT7B ADGRB1 ADGRB2 APOE CSMD2 NEDD9 DACT1 TENM3 CAPRIN2 SEMA4A PLXNB1 | 5.28e-04 | 685 | 101 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 5.59e-04 | 33 | 101 | 3 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 6.11e-04 | 34 | 101 | 3 | GO:0009218 | |
| GeneOntologyBiologicalProcess | positive regulation of inclusion body assembly | 6.52e-04 | 8 | 101 | 2 | GO:0090261 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | ADAMTSL1 WNT7B SELENOM LAMB1 ADAMTS13 APOE IGFBP3 ADAMTS7 ADAMTSL4 | 4.55e-05 | 332 | 105 | 9 | GO:0005788 |
| GeneOntologyCellularComponent | ciliary inversin compartment | 1.49e-04 | 4 | 105 | 2 | GO:0097543 | |
| GeneOntologyCellularComponent | intermediate filament | 1.50e-04 | 227 | 105 | 7 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.67e-04 | 263 | 105 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.97e-04 | 443 | 105 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTSL1 LAMA3 LAMB1 PAPLN ADAMTS13 APOE SSPOP TGFB1I1 DST ADAMTS7 ADAMTSL4 | 4.60e-04 | 656 | 105 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTSL1 LAMA3 LAMB1 PAPLN ADAMTS13 APOE SSPOP TGFB1I1 DST ADAMTS7 ADAMTSL4 | 4.72e-04 | 658 | 105 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 1.10e-03 | 10 | 105 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.33e-03 | 11 | 105 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.41e-03 | 530 | 105 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | focal adhesion | 1.49e-03 | 431 | 105 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 1.88e-03 | 13 | 105 | 2 | GO:0030877 | |
| Domain | TSP_1 | ADAMTSL1 ADGRB1 ADGRB2 PAPLN SEMA5A ADAMTS13 SSPOP ADAMTS7 ADAMTSL4 | 3.88e-11 | 63 | 98 | 9 | PF00090 |
| Domain | TSP1 | ADAMTSL1 ADGRB1 ADGRB2 PAPLN SEMA5A ADAMTS13 SSPOP ADAMTS7 ADAMTSL4 | 5.20e-11 | 65 | 98 | 9 | SM00209 |
| Domain | TSP1_rpt | ADAMTSL1 ADGRB1 ADGRB2 PAPLN SEMA5A ADAMTS13 SSPOP ADAMTS7 ADAMTSL4 | 5.20e-11 | 65 | 98 | 9 | IPR000884 |
| Domain | TSP1 | ADAMTSL1 ADGRB1 ADGRB2 PAPLN SEMA5A ADAMTS13 SSPOP ADAMTS7 ADAMTSL4 | 5.20e-11 | 65 | 98 | 9 | PS50092 |
| Domain | PLAC | 2.60e-06 | 19 | 98 | 4 | PS50900 | |
| Domain | PLAC | 2.60e-06 | 19 | 98 | 4 | IPR010909 | |
| Domain | Peptidase_M12B_ADAM-TS | 6.99e-06 | 24 | 98 | 4 | IPR013273 | |
| Domain | NDP_KINASES | 1.15e-05 | 9 | 98 | 3 | PS00469 | |
| Domain | HRM | 1.32e-05 | 28 | 98 | 4 | PF02793 | |
| Domain | NDK | 1.64e-05 | 10 | 98 | 3 | SM00562 | |
| Domain | NDK | 1.64e-05 | 10 | 98 | 3 | PF00334 | |
| Domain | GAIN_dom_N | 2.24e-05 | 11 | 98 | 3 | IPR032471 | |
| Domain | GAIN | 2.24e-05 | 11 | 98 | 3 | PF16489 | |
| Domain | GPS | 2.93e-05 | 34 | 98 | 4 | SM00303 | |
| Domain | Nucleoside_diP_kinase | 2.98e-05 | 12 | 98 | 3 | IPR001564 | |
| Domain | GPS | 3.29e-05 | 35 | 98 | 4 | PF01825 | |
| Domain | GPS | 3.69e-05 | 36 | 98 | 4 | PS50221 | |
| Domain | GPS | 4.12e-05 | 37 | 98 | 4 | IPR000203 | |
| Domain | PLAC | 4.89e-05 | 14 | 98 | 3 | PF08686 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 5.63e-05 | 40 | 98 | 4 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 5.63e-05 | 40 | 98 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 5.63e-05 | 40 | 98 | 4 | PS50227 | |
| Domain | Rhs_assc_core | 8.15e-05 | 3 | 98 | 2 | IPR022385 | |
| Domain | GPCR_2_brain_angio_inhib | 8.15e-05 | 3 | 98 | 2 | IPR008077 | |
| Domain | Serine_rich | 8.15e-05 | 3 | 98 | 2 | IPR014928 | |
| Domain | Serine_rich | 8.15e-05 | 3 | 98 | 2 | PF08824 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.36e-04 | 50 | 98 | 4 | PS00650 | |
| Domain | 7tm_2 | 1.36e-04 | 50 | 98 | 4 | PF00002 | |
| Domain | Tox-GHH_dom | 1.62e-04 | 4 | 98 | 2 | IPR028916 | |
| Domain | Ten_N | 1.62e-04 | 4 | 98 | 2 | IPR009471 | |
| Domain | Ten_N | 1.62e-04 | 4 | 98 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.62e-04 | 4 | 98 | 2 | PS51361 | |
| Domain | DUF3513 | 1.62e-04 | 4 | 98 | 2 | PF12026 | |
| Domain | Tox-GHH | 1.62e-04 | 4 | 98 | 2 | PF15636 | |
| Domain | CAS_DUF3513 | 1.62e-04 | 4 | 98 | 2 | IPR021901 | |
| Domain | CUB | 1.71e-04 | 53 | 98 | 4 | PS01180 | |
| Domain | CUB_dom | 2.27e-04 | 57 | 98 | 4 | IPR000859 | |
| Domain | ADAM_spacer1 | 2.30e-04 | 23 | 98 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.30e-04 | 23 | 98 | 3 | PF05986 | |
| Domain | Nucleoside_diP_kinase_AS | 2.70e-04 | 5 | 98 | 2 | IPR023005 | |
| Domain | YD | 2.70e-04 | 5 | 98 | 2 | IPR006530 | |
| Domain | GPCR_2_secretin-like | 2.77e-04 | 60 | 98 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 2.77e-04 | 60 | 98 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.96e-04 | 61 | 98 | 4 | PS50261 | |
| Domain | HormR | 2.96e-04 | 25 | 98 | 3 | SM00008 | |
| Domain | EGF_1 | 3.92e-04 | 255 | 98 | 7 | PS00022 | |
| Domain | EGF_2 | 4.93e-04 | 265 | 98 | 7 | PS01186 | |
| Domain | EGF_LAM_2 | 5.13e-04 | 30 | 98 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.13e-04 | 30 | 98 | 3 | PS01248 | |
| Domain | Sema | 5.66e-04 | 31 | 98 | 3 | SM00630 | |
| Domain | Semap_dom | 5.66e-04 | 31 | 98 | 3 | IPR001627 | |
| Domain | Sema | 5.66e-04 | 31 | 98 | 3 | PF01403 | |
| Domain | SEMA | 5.66e-04 | 31 | 98 | 3 | PS51004 | |
| Domain | PSI | 6.22e-04 | 32 | 98 | 3 | PF01437 | |
| Domain | Plexin_repeat | 6.22e-04 | 32 | 98 | 3 | IPR002165 | |
| Domain | Laminin_EGF | 8.12e-04 | 35 | 98 | 3 | PF00053 | |
| Domain | EGF_Lam | 8.12e-04 | 35 | 98 | 3 | SM00180 | |
| Domain | PDZ | 8.84e-04 | 141 | 98 | 5 | PF00595 | |
| Domain | Laminin_EGF | 1.03e-03 | 38 | 98 | 3 | IPR002049 | |
| Domain | PDZ | 1.10e-03 | 148 | 98 | 5 | SM00228 | |
| Domain | - | 1.17e-03 | 150 | 98 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.20e-03 | 151 | 98 | 5 | PS50106 | |
| Domain | PDZ | 1.24e-03 | 152 | 98 | 5 | IPR001478 | |
| Domain | Growth_fac_rcpt_ | 1.39e-03 | 156 | 98 | 5 | IPR009030 | |
| Domain | EGF | 1.50e-03 | 235 | 98 | 6 | SM00181 | |
| Domain | PSI | 1.59e-03 | 44 | 98 | 3 | IPR016201 | |
| Domain | PSI | 1.81e-03 | 46 | 98 | 3 | SM00423 | |
| Domain | - | 1.86e-03 | 333 | 98 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.92e-03 | 335 | 98 | 7 | IPR015943 | |
| Domain | EGF-like_dom | 2.00e-03 | 249 | 98 | 6 | IPR000742 | |
| Domain | NHL | 2.05e-03 | 13 | 98 | 2 | PS51125 | |
| Domain | CUB | 2.17e-03 | 49 | 98 | 3 | PF00431 | |
| Domain | CUB | 2.30e-03 | 50 | 98 | 3 | SM00042 | |
| Domain | EGF-like_CS | 2.53e-03 | 261 | 98 | 6 | IPR013032 | |
| Domain | - | 2.57e-03 | 52 | 98 | 3 | 2.60.120.290 | |
| Domain | Sushi | 2.57e-03 | 52 | 98 | 3 | PF00084 | |
| Domain | Spectrin_alpha_SH3 | 2.74e-03 | 15 | 98 | 2 | IPR013315 | |
| Domain | CCP | 2.86e-03 | 54 | 98 | 3 | SM00032 | |
| Domain | Laminin_N | 3.12e-03 | 16 | 98 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 3.12e-03 | 16 | 98 | 2 | PS51117 | |
| Domain | Laminin_N | 3.12e-03 | 16 | 98 | 2 | PF00055 | |
| Domain | LamNT | 3.12e-03 | 16 | 98 | 2 | SM00136 | |
| Domain | SUSHI | 3.17e-03 | 56 | 98 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.34e-03 | 57 | 98 | 3 | IPR000436 | |
| Domain | CarboxyPept-like_regulatory | 3.52e-03 | 17 | 98 | 2 | IPR008969 | |
| Domain | Trypsin | 3.79e-03 | 121 | 98 | 4 | PF00089 | |
| Domain | Trypsin_dom | 3.79e-03 | 121 | 98 | 4 | IPR001254 | |
| Domain | Peptidase_S1_PA | 4.02e-03 | 123 | 98 | 4 | IPR009003 | |
| Domain | Wnt | 4.40e-03 | 19 | 98 | 2 | IPR005817 | |
| Domain | Wnt_CS | 4.40e-03 | 19 | 98 | 2 | IPR018161 | |
| Domain | wnt | 4.40e-03 | 19 | 98 | 2 | PF00110 | |
| Domain | WNT1 | 4.40e-03 | 19 | 98 | 2 | SM00097 | |
| Domain | WNT1 | 4.40e-03 | 19 | 98 | 2 | PS00246 | |
| Domain | IGFBP-like | 4.87e-03 | 20 | 98 | 2 | IPR000867 | |
| Domain | IGFBP | 4.87e-03 | 20 | 98 | 2 | PF00219 | |
| Domain | Semaphorin | 4.87e-03 | 20 | 98 | 2 | IPR027231 | |
| Domain | IGFBP_N_2 | 4.87e-03 | 20 | 98 | 2 | PS51323 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.46e-08 | 39 | 73 | 6 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.46e-08 | 39 | 73 | 6 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.33e-06 | 68 | 73 | 6 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.08e-05 | 109 | 73 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.31e-05 | 111 | 73 | 6 | M27416 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 7.68e-05 | 44 | 73 | 4 | MM15878 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.55e-05 | 143 | 73 | 6 | M27275 | |
| Pubmed | ADAMTSL1 ADGRB1 ADGRB2 PAPLN SEMA5A ADAMTS13 SSPOP ADAMTS7 ADAMTSL4 | 2.20e-12 | 75 | 109 | 9 | 20637190 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 8270257 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ATXN2L FBF1 ADGRB2 SIPA1 AXIN1 TGFB1I1 SORBS3 NME1 COIL ADAMTSL4 MX1 | 1.58e-06 | 560 | 109 | 11 | 21653829 |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 3.48e-06 | 33 | 109 | 4 | 25713288 | |
| Pubmed | 4.43e-06 | 35 | 109 | 4 | 30940800 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PIEZO1 WNT7B ADGRB2 PAPLN ADGRA2 DACT1 DST RPAP1 CELSR2 ADAMTS7 NEK8 SORBS3 RGL2 CRAMP1 | 9.54e-06 | 1105 | 109 | 14 | 35748872 |
| Pubmed | Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1. | 9.73e-06 | 2 | 109 | 2 | 37901456 | |
| Pubmed | Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. | 9.73e-06 | 2 | 109 | 2 | 2509941 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 7488060 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8245015 | ||
| Pubmed | Coronary Disease Association With ADAMTS7 Is Due to Protease Activity. | 9.73e-06 | 2 | 109 | 2 | 34176299 | |
| Pubmed | Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease. | 9.73e-06 | 2 | 109 | 2 | 20430066 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 9.73e-06 | 2 | 109 | 2 | 24408017 | |
| Pubmed | ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. | 9.73e-06 | 2 | 109 | 2 | 22123843 | |
| Pubmed | The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. | 9.73e-06 | 2 | 109 | 2 | 32392889 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24675808 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28209562 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22687244 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22652598 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12200143 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21085602 | ||
| Pubmed | Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. | 9.73e-06 | 2 | 109 | 2 | 35259022 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12007505 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12972261 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 9.73e-06 | 2 | 109 | 2 | 27890662 | |
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 9.73e-06 | 2 | 109 | 2 | 21439553 | |
| Pubmed | Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress. | 9.73e-06 | 2 | 109 | 2 | 27634835 | |
| Pubmed | 1.47e-05 | 47 | 109 | 4 | 33141892 | ||
| Pubmed | A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. | 2.91e-05 | 3 | 109 | 2 | 28007914 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12906867 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 27114383 | ||
| Pubmed | Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. | 2.91e-05 | 3 | 109 | 2 | 9480811 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 15530864 | ||
| Pubmed | Substrate specificity of human nucleoside-diphosphate kinase revealed by transient kinetic analysis. | 2.91e-05 | 3 | 109 | 2 | 9488696 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19619546 | ||
| Pubmed | Organization and expression of mouse nm23-M1 gene. Comparison with nm23-M2 expression. | 2.91e-05 | 3 | 109 | 2 | 10452942 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 32860079 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25748386 | ||
| Pubmed | Novel roles of NM23 proteins in skin homeostasis, repair and disease. | 2.91e-05 | 3 | 109 | 2 | 16862176 | |
| Pubmed | Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. | 2.91e-05 | 3 | 109 | 2 | 11042679 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9533023 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 15225653 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8392752 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21276136 | ||
| Pubmed | nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans. | 2.91e-05 | 3 | 109 | 2 | 27604954 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 1851158 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22421058 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25712206 | ||
| Pubmed | Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? | 2.91e-05 | 3 | 109 | 2 | 14499630 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19805292 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 30411342 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 29348121 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 11277919 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8543593 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9881672 | ||
| Pubmed | GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling. | 2.91e-05 | 3 | 109 | 2 | 25558062 | |
| Pubmed | The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. | 2.91e-05 | 3 | 109 | 2 | 12517963 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 33024267 | ||
| Pubmed | ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism. | 2.91e-05 | 3 | 109 | 2 | 24261607 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 19066617 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20534451 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21765937 | ||
| Pubmed | Disrupted IRF6-NME1/2 Complexes as a Cause of Cleft Lip/Palate. | 2.91e-05 | 3 | 109 | 2 | 28767310 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22080566 | ||
| Pubmed | Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. | 2.91e-05 | 3 | 109 | 2 | 15928304 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25010650 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25587044 | ||
| Pubmed | NM23 proteins: innocent bystanders or local energy boosters for CFTR? | 2.91e-05 | 3 | 109 | 2 | 29251738 | |
| Pubmed | The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. | 2.91e-05 | 3 | 109 | 2 | 11960382 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8600152 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 5.82e-05 | 4 | 109 | 2 | 10225957 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 8668148 | ||
| Pubmed | Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. | 5.82e-05 | 4 | 109 | 2 | 22006949 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 10801807 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 9366405 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 11344214 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 28139974 | ||
| Pubmed | Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA. | 5.82e-05 | 4 | 109 | 2 | 24253523 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 9748319 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 9498705 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 29981480 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 9295052 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 30026314 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 34433909 | ||
| Pubmed | ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. | 5.82e-05 | 4 | 109 | 2 | 23793029 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 1337998 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 26299592 | ||
| Pubmed | Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation. | 5.82e-05 | 4 | 109 | 2 | 18762581 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 9360983 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 5.82e-05 | 4 | 109 | 2 | 12000766 | |
| Pubmed | Expression patterns of nm23 genes during mouse organogenesis. | 9.67e-05 | 5 | 109 | 2 | 16082520 | |
| Pubmed | Inv acts as a molecular anchor for Nphp3 and Nek8 in the proximal segment of primary cilia. | 9.67e-05 | 5 | 109 | 2 | 20169535 | |
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 8858107 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 19141611 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 12383506 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 15218527 | ||
| Pubmed | Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. | 9.67e-05 | 5 | 109 | 2 | 10502414 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.03e-04 | 29 | 109 | 3 | 15203201 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.10e-04 | 149 | 109 | 5 | 25231870 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.14e-04 | 79 | 109 | 4 | 18757743 | |
| Cytoband | Xq25 | 1.41e-04 | 41 | 112 | 3 | Xq25 | |
| GeneFamily | ADAMTS like | 2.10e-06 | 7 | 72 | 3 | 947 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 4.68e-05 | 3 | 72 | 2 | 912 | |
| GeneFamily | Cas scaffolding proteins | 9.34e-05 | 4 | 72 | 2 | 469 | |
| GeneFamily | PDZ domain containing | 3.50e-04 | 152 | 72 | 5 | 1220 | |
| GeneFamily | NME/NM23 family | 5.53e-04 | 9 | 72 | 2 | 961 | |
| GeneFamily | Laminin subunits | 1.01e-03 | 12 | 72 | 2 | 626 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.52e-03 | 57 | 72 | 3 | 1179 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.56e-03 | 19 | 72 | 2 | 50 | |
| GeneFamily | Wnt family|Endogenous ligands | 2.56e-03 | 19 | 72 | 2 | 360 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.84e-03 | 20 | 72 | 2 | 736 | |
| Coexpression | NABA_MATRISOME | ADAMTSL1 WNT7B LAMA3 LAMB1 PAPLN SEMA5A ADAMTS13 HTRA4 SSPOP IGFBP3 ADAMTS7 WNT16 SEMA4A ADAMTSL4 PLXNB1 MASP2 | 4.24e-06 | 1008 | 109 | 16 | MM17056 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | LAMA3 LAMB1 SEMA5A BCAR1 APOE ADGRA2 TGFB1I1 DST IGFBP3 TENM3 ARHGAP25 | 5.19e-06 | 479 | 109 | 11 | M2573 |
| Coexpression | NABA_MATRISOME | ADAMTSL1 WNT7B LAMA3 LAMB1 PAPLN SEMA5A ADAMTS13 HTRA4 SSPOP IGFBP3 ADAMTS7 WNT16 SEMA4A ADAMTSL4 PLXNB1 MASP2 | 5.30e-06 | 1026 | 109 | 16 | M5889 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | LAMA3 LAMB1 SEMA5A BCAR1 APOE ADGRA2 TGFB1I1 DST IGFBP3 TENM3 ARHGAP25 | 5.62e-06 | 483 | 109 | 11 | MM1082 |
| Coexpression | GOZGIT_ESR1_TARGETS_UP | 3.82e-05 | 149 | 109 | 6 | M13944 | |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 5.68e-05 | 160 | 109 | 6 | M40233 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-08 | 193 | 108 | 8 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-08 | 197 | 108 | 8 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-07 | 169 | 108 | 7 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-07 | 171 | 108 | 7 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-07 | 182 | 108 | 7 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.32e-07 | 191 | 108 | 7 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.32e-07 | 191 | 108 | 7 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.32e-07 | 191 | 108 | 7 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.32e-07 | 191 | 108 | 7 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.32e-07 | 191 | 108 | 7 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-07 | 192 | 108 | 7 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-07 | 192 | 108 | 7 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-07 | 194 | 108 | 7 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.32e-07 | 197 | 108 | 7 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 5.89e-07 | 200 | 108 | 7 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.47e-06 | 145 | 108 | 6 | 84d50a13b48d50c16e768422908e371a55972d0e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-06 | 158 | 108 | 6 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.71e-06 | 90 | 108 | 5 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-06 | 170 | 108 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-06 | 170 | 108 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-06 | 178 | 108 | 6 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-06 | 180 | 108 | 6 | f103e161e966c257eac97e1b30a461c4ed9cafc2 | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.15e-06 | 180 | 108 | 6 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 5.66e-06 | 183 | 108 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-06 | 184 | 108 | 6 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.40e-06 | 187 | 108 | 6 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 7.23e-06 | 191 | 108 | 6 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 7.23e-06 | 191 | 108 | 6 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 7.45e-06 | 192 | 108 | 6 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-06 | 192 | 108 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | COVID-19-Myeloid-TRAM2|COVID-19 / Condition, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f | |
| ToppCell | COVID-19-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | 4060a60c0271e7397b07993a1ef47b3291bba6e3 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.38e-06 | 196 | 108 | 6 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.62e-06 | 197 | 108 | 6 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.13e-06 | 199 | 108 | 6 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.40e-06 | 200 | 108 | 6 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.40e-06 | 200 | 108 | 6 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.40e-06 | 200 | 108 | 6 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 4.17e-05 | 158 | 108 | 5 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 158 | 108 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 158 | 108 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 159 | 108 | 5 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 159 | 108 | 5 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.57e-05 | 161 | 108 | 5 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-05 | 162 | 108 | 5 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.84e-05 | 163 | 108 | 5 | a53294b229fc24d4a574f0c156755b4fa7c757fc | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-05 | 169 | 108 | 5 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-05 | 169 | 108 | 5 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.08e-05 | 171 | 108 | 5 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-05 | 172 | 108 | 5 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-05 | 172 | 108 | 5 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-05 | 172 | 108 | 5 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 172 | 108 | 5 | 1cfea985c5959b38beea351b892cd5e92e27f927 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-05 | 173 | 108 | 5 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 174 | 108 | 5 | ccc59416548ed3b783fd7a050ab32076c4296254 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-05 | 174 | 108 | 5 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-05 | 175 | 108 | 5 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 175 | 108 | 5 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.96e-05 | 176 | 108 | 5 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.15e-05 | 177 | 108 | 5 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.35e-05 | 178 | 108 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-05 | 179 | 108 | 5 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.54e-05 | 179 | 108 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.74e-05 | 180 | 108 | 5 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-05 | 181 | 108 | 5 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-05 | 181 | 108 | 5 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-05 | 181 | 108 | 5 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-05 | 182 | 108 | 5 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.16e-05 | 182 | 108 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-05 | 182 | 108 | 5 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-05 | 182 | 108 | 5 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-05 | 182 | 108 | 5 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 184 | 108 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 8.59e-05 | 184 | 108 | 5 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| Disease | tricosanoyl sphingomyelin (d18:1/23:0) measurement | 1.07e-05 | 2 | 97 | 2 | EFO_0800401 | |
| Disease | behenoyl sphingomyelin (d18:1/22:0) measurement | 1.07e-05 | 2 | 97 | 2 | EFO_0800376 | |
| Disease | Colorectal Carcinoma | TTLL3 FRMPD2 ADARB2 KRT73 PPOX DACT1 IGFBP3 RPAP1 WNT16 NME1 NME2 | 1.99e-05 | 702 | 97 | 11 | C0009402 |
| Disease | response to darapladib, lipoprotein-associated phospholipase A(2) change measurement | 3.20e-05 | 3 | 97 | 2 | EFO_0008395, EFO_0008432 | |
| Disease | angina pectoris | 5.94e-05 | 125 | 97 | 5 | EFO_0003913 | |
| Disease | palmitoyl sphingomyelin (d18:1/16:0) measurement | 6.39e-05 | 4 | 97 | 2 | EFO_0800300 | |
| Disease | teratoma (is_implicated_in) | 1.06e-04 | 5 | 97 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | LDL cholesterol change measurement | 2.22e-04 | 7 | 97 | 2 | EFO_0007804 | |
| Disease | nucleoside diphosphate kinase B measurement | 2.22e-04 | 7 | 97 | 2 | EFO_0020615 | |
| Disease | aspirin use measurement | 2.89e-04 | 39 | 97 | 3 | EFO_0007013 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 2.96e-04 | 8 | 97 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | NEPHRONOPHTHISIS 2 | 2.96e-04 | 8 | 97 | 2 | C1865872 | |
| Disease | Nephronophthisis | 3.79e-04 | 9 | 97 | 2 | cv:C0687120 | |
| Disease | repulsive guidance molecule A measurement | 3.79e-04 | 9 | 97 | 2 | EFO_0008273 | |
| Disease | urinary bladder cancer (is_marker_for) | 4.37e-04 | 107 | 97 | 4 | DOID:11054 (is_marker_for) | |
| Disease | carboxypeptidase B2 measurement | 4.73e-04 | 10 | 97 | 2 | EFO_0008069 | |
| Disease | coronary artery disease, factor VII measurement | 5.02e-04 | 111 | 97 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.02e-04 | 111 | 97 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | factor VIII measurement, coronary artery disease | 5.37e-04 | 113 | 97 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 5.74e-04 | 115 | 97 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | beta thalassemia (is_marker_for) | 5.77e-04 | 11 | 97 | 2 | DOID:12241 (is_marker_for) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.32e-04 | 118 | 97 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Metastatic melanoma | 7.56e-04 | 54 | 97 | 3 | C0278883 | |
| Disease | Antithrombotic agent use measurement | 7.98e-04 | 55 | 97 | 3 | EFO_0009925 | |
| Disease | phosphocreatine measurement | 8.15e-04 | 13 | 97 | 2 | EFO_0010521 | |
| Disease | Nephronophthisis | 8.15e-04 | 13 | 97 | 2 | C0687120 | |
| Disease | CD209 antigen measurement | 9.49e-04 | 14 | 97 | 2 | EFO_0008077 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 9.49e-04 | 14 | 97 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | myocardial infarction | 1.07e-03 | 350 | 97 | 6 | EFO_0000612 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.09e-03 | 15 | 97 | 2 | EFO_0007804, GO_0036273 | |
| Disease | response to triptolide, cytotoxicity measurement | 1.25e-03 | 16 | 97 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 1.41e-03 | 17 | 97 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.41e-03 | 17 | 97 | 2 | EFO_0022232 | |
| Disease | rosacea severity measurement | 1.43e-03 | 147 | 97 | 4 | EFO_0009180 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 1.58e-03 | 18 | 97 | 2 | OBA_2045175 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.58e-03 | 18 | 97 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | creatinine measurement | WNT7B LHX3 APOE ADARB2 SHF DCAF12L1 CELSR2 ADAMTS7 TMEM132E-DT SLC47A1 | 1.62e-03 | 995 | 97 | 10 | EFO_0004518 |
| Disease | HbA1c measurement | 1.74e-03 | 675 | 97 | 8 | EFO_0004541 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.76e-03 | 19 | 97 | 2 | EFO_0802076 | |
| Disease | axial length measurement | 2.11e-03 | 77 | 97 | 3 | EFO_0005318 | |
| Disease | stroke, coronary artery disease | 2.16e-03 | 21 | 97 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | lung cancer | 2.16e-03 | 21 | 97 | 2 | MONDO_0008903 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.16e-03 | 21 | 97 | 2 | EFO_0022246 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.23e-03 | 166 | 97 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Colorectal Neoplasms | 2.24e-03 | 277 | 97 | 5 | C0009404 | |
| Disease | clinical and behavioural ideal cardiovascular health | 2.59e-03 | 23 | 97 | 2 | EFO_0007654 | |
| Disease | prostate carcinoma | ADAMTSL1 H1-7 DCAF12L2 NEDD9 MGAT5 ADAMTSL4 CRAMP1 MTMR9 SEC14L5 | 2.68e-03 | 891 | 97 | 9 | EFO_0001663 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.78e-03 | 291 | 97 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | airway responsiveness measurement | 2.82e-03 | 24 | 97 | 2 | EFO_0006897 | |
| Disease | liver fibrosis measurement | 2.89e-03 | 86 | 97 | 3 | EFO_0010576 | |
| Disease | Back pain | 2.99e-03 | 87 | 97 | 3 | HP_0003418 | |
| Disease | total brain volume change measurement, age at assessment | 3.05e-03 | 25 | 97 | 2 | EFO_0008007, EFO_0021504 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQGLQVRTRSCVSSP | 326 | O60241 | |
| SGPRRTQAQLLRVGC | 96 | Q7Z4H4 | |
| SRGSVCSVCGEPRGR | 91 | A0A494C0Y3 | |
| SRGSVCSVCGEPRGR | 91 | A0A494C0N9 | |
| RGCPGGDVETAQRLS | 6 | Q5RGS3 | |
| GRVRAATVGSLAGQP | 206 | P02649 | |
| CSQPCGVGVQRRSRT | 56 | Q6UY14 | |
| GVGVQRRSRTCQLPT | 61 | Q6UY14 | |
| CRARTCGSNLRGPSG | 406 | Q96PZ7 | |
| TCVVPCGGNLTERRG | 1791 | Q7Z408 | |
| CGGNLTERRGTILSP | 1796 | Q7Z408 | |
| CSLHGRQGIVPGNRV | 46 | Q14511 | |
| CSLHGRQGIVPGNRL | 46 | P56945 | |
| LTCTAFQRREGGVPG | 556 | Q96PE1 | |
| DCGGGLQTRTRTCLP | 276 | O14514 | |
| EGTRGCSDRQPGVLT | 6 | O75388 | |
| SVEQVGGERCRGPQS | 1011 | Q96L96 | |
| GDQVGPCRSLGSRGR | 31 | Q9HCU4 | |
| APSGCIGGLGARVTR | 61 | Q13515 | |
| GQLCGRSARPQTGGT | 56 | Q8N2F6 | |
| TNTLVVRQRCGRPGG | 1266 | Q76LX8 | |
| GPGGLSRRAVLCIRS | 896 | Q9UKP4 | |
| VREGPRGGVRCSSSR | 356 | Q8WWM7 | |
| VGPCVRGRRITSAGG | 141 | Q6UXT9 | |
| INATTGRRSCGGPSR | 651 | Q9NS39 | |
| PGTIRGDFCIQVGRN | 101 | P22392 | |
| SVRSLGARSGCGPRA | 31 | A6NH11 | |
| VTGQCECRPGVTGQR | 551 | Q16787 | |
| GSGNCSPRGEARTRL | 501 | Q86Y46 | |
| VVGNRSGCPTVGDRI | 331 | Q09328 | |
| RSGQPLTGTNGRRCK | 201 | Q96QG7 | |
| RPQEGGRITLKCGRN | 1741 | Q03001 | |
| IRPLCSREGGTGVRS | 341 | Q5VW00 | |
| ACTRSCGGGVQTRRV | 1556 | Q8N6G6 | |
| GRCSRRSECSRGQGP | 506 | O43157 | |
| SRRGPSCRQGRGIQK | 1256 | Q9H792 | |
| RGCPGGDVETAQRLS | 6 | Q4VXF1 | |
| GRGRGHPVSCVVNRS | 416 | P38432 | |
| GQLGTNTRRGSRAPC | 591 | Q86SG6 | |
| VQRPGRIPTSSRCGN | 631 | P07942 | |
| RARPGAAAVCTLGGT | 11 | Q9UBR4 | |
| LGLSVGPRTCVQAGT | 11 | O75023 | |
| PCLRIQGTLRGDGTA | 181 | Q68DD2 | |
| VGGPSRGCSSSVLRV | 46 | Q75WM6 | |
| TPGGRTLERDVGCTR | 1376 | Q9Y2H9 | |
| RGCPGGDVETVQRLS | 6 | A6NL05 | |
| QVGRGTQLRTGRPCS | 6 | Q8IVV7 | |
| RAPGRGQQGLTREAC | 831 | Q99575 | |
| PGAGGSALRCRAQRV | 26 | P15863 | |
| LCGGDGRPRQATQRL | 211 | P07199 | |
| GGSSGTTARERPCVR | 476 | Q8TES7 | |
| NCGDTGTRSAGPLRR | 151 | P83105 | |
| GQNVSLRCRGPVDGV | 336 | Q8N6C5 | |
| LRNGSVCVRAPGGVS | 371 | Q9NYF0 | |
| SPIRARAGSEGRGCQ | 86 | A1L168 | |
| RAGSEGRGCQPVCSR | 91 | A1L168 | |
| GRGCQPVCSRGLAQL | 96 | A1L168 | |
| AEGIGRSPCTGREQL | 716 | Q68DX3 | |
| RCVQRGPGLVAGANI | 856 | Q9P278 | |
| TRSQRKVGGGSAQPC | 766 | O15169 | |
| PQARGTGQRVGSRAT | 41 | P54257 | |
| QPRCCAQLLSGRGGS | 86 | A2RUQ5 | |
| QSGQGTARGQVKCPR | 451 | Q96RY5 | |
| EGRCQTQPRSSPSGR | 6 | Q6NUI2 | |
| QRKTGPVSLANGCGR | 1581 | Q9NSI6 | |
| VNSRGSVRGCTRGGR | 856 | Q6IMN6 | |
| SVRGCTRGGRLITNS | 861 | Q6IMN6 | |
| EPVCGLSARTTGGRI | 431 | O00187 | |
| IRPLCSREGGTGVRS | 341 | Q5VU92 | |
| SRGQGPGSRVSCRRD | 136 | Q9H2J1 | |
| RPNNVCTGVLTRRGG | 181 | P20160 | |
| GQKRCEGSTRQLGRP | 361 | O43304 | |
| TRAAAPGRLQGRLCS | 326 | P59044 | |
| IRSVGSCRVPSLAGA | 31 | O76013 | |
| QELRGGRCSPAGSSR | 796 | Q9Y283 | |
| RAGASSAGLGPVVRC | 26 | P17936 | |
| RGCPGGDVETAQRLS | 6 | Q5TZK3 | |
| CSISVTARRLLGGPG | 6 | Q9BPW8 | |
| GSGPGASDCRIIRVQ | 641 | O15211 | |
| GLTRARVETCGGUQL | 36 | Q8WWX9 | |
| TLSGQGCRGPRQDLE | 3846 | A2VEC9 | |
| PGTIRGDFCIQVGRN | 101 | P15531 | |
| PGTIRGDFCIQVGRN | 86 | O60361 | |
| RARGKVQGCETLRPG | 711 | Q9H3S1 | |
| TCLPSVTRGQRLAAG | 66 | Q587I9 | |
| RRGPQLVCTGSDDGT | 161 | Q96DI7 | |
| GLRPGARLLRVCGQT | 721 | Q96FS4 | |
| SGRSCRGQLVQVSRP | 31 | Q9UIL1 | |
| GNGRRRSISCPSCNG | 1216 | Q9NT68 | |
| ASRGRQGCLLVPART | 11 | Q9NY99 | |
| GLRSSVGPAVQARGV | 16 | O75251 | |
| RGGPEATLEVRGSRC | 11 | Q96FL8 | |
| TPRHGGRVCVGQNRE | 626 | Q13591 | |
| EPRGLRRASGVGSSC | 46 | B7Z368 | |
| SRGVSVLRGQPVCGL | 246 | P50336 | |
| SVGTQGRLCNRTSPG | 286 | P56706 | |
| VPERLRQGSCGVGRA | 11 | A6NKD2 | |
| ARTPAGTICTGARQL | 26 | P82912 | |
| APCRTGTLEGSRQGS | 11 | Q7M4L6 | |
| TVPSLCTEARAGRGG | 56 | Q96NJ1 | |
| ATCRLCGRQVSRGPG | 76 | Q9BTP6 | |
| CGRQVSRGPGVNVGT | 81 | Q9BTP6 | |
| PRSAVQGGCRVLGSA | 131 | Q96FF7 | |
| QRRDGGSSCVGPARS | 56 | O95428 | |
| LRRVAGTPCGVFGQR | 146 | P42331 | |
| GNGRRRSISCPSCNG | 1151 | Q9P273 | |
| RGTRVPVIRNGGSNT | 31 | O60504 | |
| GIPGTQGRECNRTSE | 301 | Q9UBV4 | |
| NLGVCGSRNGAICPR | 91 | M5A8F1 | |
| IAVGGSRVDGARPCT | 751 | Q9Y4R7 | |
| LGSSRVPRCGQGTLL | 1031 | Q9BWH6 | |
| RVIRGVGRCSDPNLG | 131 | Q8NA96 | |
| SRGREGRLRPQCAGS | 151 | Q8N9X3 | |
| ACNPSTLGGRGGRIT | 651 | Q86V71 | |
| GTIGRRRANGSVAPQ | 1616 | O60346 | |
| GPCGRRVITSRIVGG | 31 | Q9Y6M0 | |
| SRRGVPTQAKGLCGS | 216 | O43294 | |
| LGICGRLARNTRQSP | 136 | Q92508 | |
| RRCDSGGSATRQGSP | 151 | Q6NSI3 | |
| SGVALPRGSGIVTRC | 91 | P20591 |